Do CA125 response criteria overestimate tumour response in second-line treatment of epithelial ovarian carcinoma?

Recent studies indicate that cancer antigen 125 (CA125) response criteria tend to overestimate a tumour reduction measured by standard WHO response criteria in recurrent epithelial ovarian carcinoma. The aim of the study was to validate the recently introduced GCIG (The Gynaecological Cancer Intergr...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Gronlund, B, Hansen, H H, Høgdall, C, Høgdall, E V S, Engelholm, S A
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2004
Soggetti:
Clinical
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2409573/
https://ncbi.nlm.nih.gov/pubmed/14735180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601501
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi